Journal of Scientific Dentistry

Register      Login

VOLUME 4 , ISSUE 2 ( July-December, 2014 ) > List of Articles

ORIGINAL RESEARCH

Estimation of Malondialdehyde Level in Oral Submucous Fibrosis

Poorani R, Vezhavendhan N, Ramesh Ramasamy, Vidhya Lakshmi S, Sivaramakrishnan M, Suganya R

Keywords : Malondialdehyde,Oral submucous fibrosis

Citation Information : R P, N V, Ramasamy R, S VL, M S, R S. Estimation of Malondialdehyde Level in Oral Submucous Fibrosis. 2014; 4 (2):9-13.

DOI: 10.5005/jsd-4-2-9

License: CC BY-NC 4.0

Published Online: 00-12-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Oral submucous fibrosis are the common Potentially Malignant Disorders prevailing in India. The primary etiological factor include arecanut which contain numerous Reactive Oxygen Species (ROS). Malondialdehyde (MDA) is the end product of lipid peroxidation and it is mutagenic and tumorigenic. Aims and Objectives: To estimate the serum Malondialdehyde level in Oral submucous fibrosis. Methodology: The control group comprised twenty normal individuals (Group 1). The experimental group comprised twenty patients with oral submucous fibrosis (Group 2). Blood samples were obtained and evaluated for serum Malondialdehyde and antioxidants level. Serum Malondialdehyde level was estimated using TBARS assay by Spectrophotometric method. Results: The present study revealed a statistically significant increase in serum MDA level in OSMF patients in comparison with corresponding normal individuals. Conclusion: While the oxidant (Malondialdehyde) levels are increased, indicating the potential role in premalignancy status, it is important to see from a larger sample if these results are reproducable and if so can it be sensitively used in detection of these potentially malignant disorders (Oral submucous fibrosis).


PDF Share
  1. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; 36:575.80.
  2. World Health Organization. World Health Organization Classification of Tumours. In: Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology & Genetics. Head and Neck Tumours. Lyon: International Agency for Research on Cancer (IARC) IARC Press. 2005;2:177.9.
  3. Free radicals and antioxidants. Vasudevan, Sreekumari, Kannan. Textbook of Biochemistry. Seventh edition, Jaypee,2013.p.433-438.
  4. Kumar, Abbas, Fausto, Aster. Cellular Responses to Stress & Toxic Insults: Adaptation, Injury & Death. Robbins and Cotran Pathologic Basis of Disease. Eighth edition, Elsevier,2010.p.20-22.
  5. Revant H Chole, Ranjitkumar N Patil, Anjan Basak, Kamlesh Palandurkar, Rahul Bhowate. Estimation of serum Malondialdehyde in Oral Cancer and Precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of Cancer Research and Therapeutics. 2010;6(1):487-491.
  6. Michael Lieberman, Allan D. Marks. Oxygen toxicity and free radical injury. Mark.s Basic Medical Biochemistry. Fourth edition, Lippincott Williams and Wilkins,2013.p.437-455.
  7. World Health Organization Collaborating Centre for Oral Precancerous lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518–39.
  8. Phatak A. Fibrin producing factor in oral submucous fibrosis. Indian Journal of Otolaryngology and head and neck surgery. 1979; 31(4): 103-4.
  9. Amagasa T, Yamashiro M, Ishikawa H. Oral leukoplakia related to malignant transformation. Oral Sci Int. 2006; 3: 45.55.
  10. Darius K. Paissat. Oral submucous fibrosis. Int. J. Oral Surg. 1981;10:307-312.
  11. Gutteridge. Lipid peroxidation and Antioxidants as Biomarkers of Tissue Damage. Clin. Chem. 1995; 41: 1819-1828.
  12. Niedernhofer et al. Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human cells. The Journal of biological chemistry. 2003; 278 (33): 31426.31433.
  13. Soma Gupta, M. V. R. Reddy et al. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem. 2004; 19(1): 138.141.
  14. Suryakant B Metkari, Tupkari, Barpande. An estimation of serum malondialdehyde, superoxide dismutase and vitamin A in oral submucous fibrosis and its clinicopathologic correlation. JOMFP. 2007; 11(1): 23-27.
  15. D. Souza D, Subhas BG, Shetty SR, Balan P. Estimation of serum malondialdehyde in potentially malignant disorders and post- antioxidant treated patients: a biochemical study. Contemp Clin Dent. 2012; 3(4): 448-451.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.